SPL
UTHR icon

Superior Planning, LLC’s United Therapeutics UTHR Stock Holding History

Superior Planning, LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$28.2K Buy
+52
New +$26.9K 0.01% 567

Other funds holding UTHR

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Superior Planning, LLC's UTHR Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in United Therapeutics (UTHR) in Q3 2026: 52 shares worth $28.2K. The stake represents 0.01% of the portfolio and ranks #567 among its holdings.

561 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Superior Planning, LLC held 52 shares of United Therapeutics worth $28.2K as of Q3 2026.
  • United Therapeutics was a new Superior Planning, LLC position in Q3 2026.
  • United Therapeutics made up 0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #567 holding.
  • 561 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.